Heparan sulfate enhances the self-renewal and therapeutic potential of mesenchymal stem cells from human adult bone marrow

scientific article

Heparan sulfate enhances the self-renewal and therapeutic potential of mesenchymal stem cells from human adult bone marrow is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1089/SCD.2011.0367
P932PMC publication ID3402859
P698PubMed publication ID22066689

P50authorAndre J van WijnenQ60974897
Gary S SteinQ88625567
Simon M CoolQ89748654
Victor NurcombeQ93333970
Zophia X H LimQ117270543
P2093author name stringBina Rai
Wanjin Hong
Christian Dombrowski
James H Hui
Torben Helledie
David A Rider
Ian Lee Hock Hin
P2860cites workMonolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction.Q50734767
Matrix-mediated retention of in vitro osteogenic differentiation potential and in vivo bone-forming capacity by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.Q51187329
FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells.Q51589137
Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC.Q52001009
Resampling methods for variance estimation of singular value decomposition analyses from microarray experiments.Q52034437
Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp.Q52107163
Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells.Q52119168
Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression.Q52119170
Developmental Regulation of Neural Response to FGF-1 and FGF-2 by Heparan Sulfate ProteoglycanQ52225676
Locally applied osteogenic predifferentiated progenitor cells are more effective than undifferentiated mesenchymal stem cells in the treatment of delayed bone healing.Q52912019
Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells.Q53358865
Autocrine fibroblast growth factor 2 increases the multipotentiality of human adipose-derived mesenchymal stem cells.Q54541100
Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populationsQ59696056
Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host DiseaseQ63197317
A Defined Medium and Substrate for Expansion of Human Mesenchymal Stromal Cell Progenitors That Enriches for Osteo- and Chondrogenic PrecursorsQ63459914
Repair of large bone defects with the use of autologous bone marrow stromal cellsQ73482003
Tissue-engineered bone regenerationQ74268240
Mesenchymal stem cells in osteobiology and applied bone regenerationQ77902271
Characterization of nonexpanded mesenchymal progenitor cells from normal adult human bone marrowQ81330304
Telomere measurement by quantitative PCRQ24529938
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesQ27860739
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementQ27861120
Heparan sulfate mediates the proliferation and differentiation of rat mesenchymal stem cellsQ28580650
Oncogenic pathway signatures in human cancers as a guide to targeted therapiesQ29615526
Pluripotency of mesenchymal stem cells derived from adult marrowQ29617959
Singular value decomposition for genome-wide expression data processing and modelingQ29618495
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cellsQ29618766
Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cellsQ30454202
Differential exoprotease activities confer tumor-specific serum peptidome patternsQ33230965
Differences between in vitro viability and differentiation and in vivo bone-forming efficacy of human mesenchymal stem cells cultured on PCL-TCP scaffoldsQ33650551
Heparan sulfate: growth control with a restricted sequence menuQ34328757
SSEA-4 identifies mesenchymal stem cells from bone marrowQ34576375
The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cellsQ34704081
Mesenchymal stem cells and their potential as cardiac therapeuticsQ35830869
Human bone marrow mesenchymal stem cells in vivoQ36994690
Long-term in vitro expansion alters the biology of adult mesenchymal stem cellsQ37269767
Optimizing mesenchymal stem cell-based therapeutics.Q37604019
Mechanisms involved in the therapeutic properties of mesenchymal stem cellsQ37635499
Number and proliferative capacity of osteogenic stem cells are maintained during aging and in patients with osteoporosisQ38300172
Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural developmentQ38339362
Selection using the alpha-1 integrin (CD49a) enhances the multipotentiality of the mesenchymal stem cell population from heterogeneous bone marrow stromal cellsQ40095061
Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cellsQ40375826
Expression of the developmental markers STRO-1 and alkaline phosphatase in cultures of human marrow stromal cells: regulation by fibroblast growth factor (FGF)-2 and relationship to the expression of FGF receptors 1-4.Q40865830
Human marrow stromal precursors are alpha 1 integrin subunit-positiveQ40866247
The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitroQ40994591
Development of novel monoclonal antibodies that define differentiation stages of human stromal (mesenchymal) stem cellsQ41864248
Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cellsQ42482834
Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitroQ42529073
Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applicationsQ43898390
Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow.Q45859658
Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiateQ45863683
STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD166) as markers of primitive human marrow stromal cells and their more differentiated progeny: a comparative investigation in vitroQ45864121
The stimulation of healing within a rat calvarial defect by mPCL-TCP/collagen scaffolds loaded with rhBMP-2.Q46151556
Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cellsQ46284854
Molecular mechanisms of FGF-2 inhibitory activity in the osteogenic context of mouse adipose-derived stem cells (mASCs).Q46638492
P433issue11
P304page(s)1897-1910
P577publication date2012-01-18
P1433published inStem Cells and DevelopmentQ15724421
P1476titleHeparan sulfate enhances the self-renewal and therapeutic potential of mesenchymal stem cells from human adult bone marrow
P478volume21

Reverse relations

cites work (P2860)
Q50865098A Versatile Protocol for Studying Calvarial Bone Defect Healing in a Mouse Model.
Q38215555Advances in mesenchymal stem cell-based strategies for cartilage repair and regeneration
Q38292089Affinity Selection of FGF2-Binding Heparan Sulfates for Ex Vivo Expansion of Human Mesenchymal Stem Cells
Q37716635Cell-autonomous heparanase modulates self-renewal and migration in bone marrow-derived mesenchymal stem cells
Q47095797Concise Review: Multifaceted Characterization of Human Mesenchymal Stem Cells for Use in Regenerative Medicine.
Q33426878Effect of heparin on the biological properties and molecular signature of human mesenchymal stem cells
Q37718020Establishing criteria for human mesenchymal stem cell potency
Q46054367Exploiting Heparan Sulfate Proteoglycans in Human Neurogenesis-Controlling Lineage Specification and Fate
Q42363800Heparan Sulfate: A Potential Candidate for the Development of Biomimetic Immunomodulatory Membranes
Q64059120Heparin Differentially Impacts Gene Expression of Stromal Cells from Various Tissues
Q37170068Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production
Q34509764Immobilization of heparan sulfate on electrospun meshes to support embryonic stem cell culture and differentiation
Q38395222Mesenchymal Stem/Stromal Cells in Liver Fibrosis: Recent Findings, Old/New Caveats and Future Perspectives
Q33722683Microfluidic Screening Reveals Heparan Sulfate Enhances Human Mesenchymal Stem Cell Growth by Modulating Fibroblast Growth Factor-2 Transport
Q58799277Periodontal reconstruction by heparan sulfate mimetic-based matrix therapy in -infected mice
Q58676364Presentation of functional groups on self-assembled supramolecular peptide nanofibers mimicking glycosaminoglycans for directed mesenchymal stem cell differentiation
Q60046880Recombinant Heparin-New Opportunities
Q37634126XYLT1 mutations in Desbuquois dysplasia type 2.

Search more.